LP
Lakshmi Prabhu
Gilead Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Indiana University School of Medicine
Employment
-
Gilead Sciences Research Scientist2021 - Present
-
Boehringer Ingelheim Pharmaceuticals Inc Postdoctoral Associate? - 2021
Education
-
Indiana University School of Medicine2013 - 2018
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue Save
- PRMT5 is a therapeutic target in choroidal neovascularization Save
- Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer Save
- Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases Save
- Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers Save
- Novel serine 176 phosphorylation of YBX1 activates NF-κB in colon cancer Save
- Role of post-translational modification of the Y box binding protein 1 in human cancers Save
- Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer Save
- Role of novel serine 316 phosphorylation of the p65 subunit of NF-κB in differential gene regulation Save
- Critical role of NF-κB in pancreatic cancer Save